|
Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870; TTY/TDD Users 1-800-735-2258 - [E-mail Us] DOCKETS ENTERED on October 21, 2002 TABLE OF CONTENTS Hyper links are part of the Docket title - not all dockets/documents are linked NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence. |
|
99P-2630 Establish a Daily Value for "added sugars"
ANS 1 HFW-1 to Honorable Bernard Sanders Vol#: 32
00D-1598 Voluntary Labeling for Bioengineered Foods
C 9834 Jeannette Lee Vol#: 572
01D-0005 Labeling OTC Human Drug Products;Updating Labeling in ANDA's
GDL 2 GUIDANCE Vol#: 1
NAD 2 Vol#: 1
01N-0067 Reclassification of Dental Mercury
C 113 Sherryl B. Ruth Vol#: 15
01N-0590 Salmonella Discovery System Pilot Study;Information Collecti
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
01P-0252 ANDA Suitability for Dextroamphetamine Sulfate Tablets 15 mg
LET 2 HFD-7 to Mallinckrodt, Inc. Vol#: 1
N 1 Vol#: 1
01P-0574 Referencing discontinued labeling for Octreotide acetate inj
C 2 Mitchell Berger Vol#: 1
02D-0005 Pharmacovigilance of Veterinary Medicinal Products
NAD 2 Vol#: 1
02D-0320 Hold following clinical investigator misconduct
C 1 Bristol-Myers Squibb Vol#: 1
02D-0350 Handling and Retention of Bioavailability and Bioequivalence
N 1 Vol#: 1
02D-0428 Information for the use of Human Blood & Blood Components
GDL 1 GUIDANCE Vol#: 1
NAD 1 Vol#: 1
02N-0070 Regulations for In Vivo radiopharmaceuticals
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
02N-0204 Bar Code Label Requirements for human drug products
C 20 Johns Hopkins Bayview Medical Center Vol#: 7
C 21 University of Chicago Vol#: 7
EMC 166 University of Auckland Vol#: 7
EMC 167 EAN Switzerland Vol#: 7
EMC 168 Upstate Medical University Vol#: 7
EMC 169 Richard Hinkle Vol#: 7
EMC 170 Dr. Tess Pape, PhD, RN, CNOR Vol#: 7
LST 4 Final Agenda 8/26/02 meeting (Barcoding) Vol#: 7
TS 22 American Medical Assn Vol#: 7
TS 23 American Society of Health-System Pharma Vol#: 7
TS 24 Rack Design Group, Inc. Vol#: 7
TS 25 Federation of American Hospitals Vol#: 7
TS 26 Healthcare Leadership Council Vol#: 7
TS 27 American Hospital Assn Vol#: 7
TS 29 Institute for Safe Medication Practices Vol#: 7
TS 31 National Assn of Chain Drug Stores Vol#: 7
TS 32 Consumer Healthcare Products Assn Vol#: 7
02N-0259 FDA Lyme Vaccine Safety Study
N 2 Vol#: 1
02N-0278 Bioterrorism;Prior Notice of Imported Food Shipments
C 28 Fresh Produce Assn of the Americas Vol#: 3
02N-0296 Investigational New Drug Regulations;Agency Information Coll
N 2 Vol#: 1
02N-0302 Formal Meetings With Sponsors and Applicants for PDUFA Produ
N 2 Vol#: 1
02N-0315 Humanitarian Use Devices
N 2 Vol#: 1
02P-0225 ANDA for Levorphanol Tartrate Tablets
PAV 1 HFD-600 to Lachman Consultant Services, Vol#: 1
02P-0459 Abbreviated new drug application(ANDA) for Metoprolol tartrt
CP 1 Lachman Consultant Services Inc. Vol#: 1
02P-0460 25 mg metoprolol tartrate tablets drug product of ANDA
CP 1 Caraco Pharmaceutical Labs., Ltd. Vol#: 1
02V-0458 Laser Light Show
ACK 1 HFA-305 Vol#: 1
VAR 1 Columbia DJ Supply Vol#: 1